Interference of blood plasma components in turbidimetric D-dimer estimation
Authors:
F. Mareček; M. Zemanová; J. Mejtská; D. Češpivová; I. Malíková; I. Hrachovinová
Authors‘ workplace:
Ústav lékařské biochemie a laboratorní diagnostiky a 1. LF UK Praha, Centrální hematologická laboratoř
; Ústav hematologie a krevní transfuze v Praze, Laboratoř pro poruchy hemostázy
Published in:
Transfuze Hematol. dnes,21, 2015, No. 1, p. 30-34.
Category:
Comprehensive Reports, Original Papers, Case Reports
Overview
Two immunoturbidimetric D-dimer assays were tested in terms of their resistance to plasma interferents. The Diagnostica Stago products STA LIATEST DDi and its new version STA LIATEST D-Di Plus were used to detect D-dimer concentrations in samples with confirmed presence of interferents. A solid phase immunoassay with fluorimetric detection VIDAS® D-Dimer ExclusionTM was used as the reference method. In the group of 12 samples containing interferents false positivity was detected in all 12 cases during testing with the STA LIATEST DDi kit. Results using the STA LIATEST DDi Plus kit were falsely positive in 4 cases. A correlation study on plasma samples with a range of 70–12000 μg/l – FEU was carried out. The coefficient of correlation between both assays was R2 = 0.9944. Precision studies of STA LIATEST DDi Plus were performed with the control samples on normal and pathological level. Intra-assay precision (expressed as coefficient of variation) was 7.38% on normal and 1.61% on pathological D-dimer levels. Inter-assay coefficient of variation values were 7.78% on the normal and 2.16% on the pathological D-dimer levels. The working range of the D-dimer concentration of STA LIATEST DDi Plus is up to 20000 μg/l–FEU. An increased resistance of the STA LIATEST DDi Plus to interferents was demonstrated.
Keywords:
D-dimer, thrombosis, matrix effect, rheumatoid factor, immunochemical diagnostics
Sources
1. Selby C. Interference in immunoassay. Ann Clin Bioch 1999; 36: 704–721.
2. Wadhwa M, Bird C, Dilger P, Gaines-Das R, Thorpe R. Strategies, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. J Immunol Meth 2003; 278: 1–17.
3. Šmídl P. Návaznost kalibrace imunochemických měření. In Vitro Diagnostika 2008; 8: 14–15.
4. Šmídl, P. Korelace mezi komerčně dostupnými imunochemickými metodami. In Vitro Diagnostika 2008; 9: 21–22.
5. Příbalový leták diagnostické soupravy Diagnostica Stago STA LIATEST D-Di (kat. č. 00515), verze srpen 2012.
6. Příbalový leták diagnostické soupravy Diagnostica Stago STA LIATEST D-DiPlus (kat. č. 00662), verze srpen 2012.
7. Šmídl P. Nejistoty imunochemických stanovení. Klin Bioch Metabol 2008; 16(1): 46–47.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2015 Issue 1
Most read in this issue
- Infectious complications of induction therapy in acute myeloid leukaemia patients without the use of antibiotic prophylaxis
- Interference of blood plasma components in turbidimetric D-dimer estimation
- Invasive fungal infections following autologous hematopoietic stem cell transplantation in patients with multiple myeloma
- Engraftment of acute and chronic myeloid leukemia in NOD scid gamma mice